LINCOLN, NEBRASKA (RFD NEWS) — A new vaccine is showing promise in combating Highly Pathogenic Avian Influenza (HPAI), with testing currently underway in mice and dairy calves. The promising research is led by the University of Nebraska–Lincoln (UNL).
UNL Professor of Biological Sciences Eric Weaver joined us on Tuesday’s Market Day Report to provide an update on the development.
In his interview with RFD News, Weaver discussed details of the vaccine and the results from early testing. He also outlined the next steps in the research process as work continues.
Finally, Weaver explained the potential impacts this vaccine could have on the livestock industry as it continues to battle HPAI.
Related Stories
Pennsylvania Secretary of Agriculture Russell Redding discusses the recent surge in bird flu cases, the state’s expanded biosecurity response and efforts to support poultry producers.
Higher livestock prices reflect resilient demand, even as disease and herd shifts reshape 2026 supply expectations.
Georgia has regained its HPAI-free status after a swift response to October’s detection. Commissioner Tyler Harper urges producers to stay vigilant and maintain biosecurity.
A smaller U.S. turkey flock and resurgent avian flu have tightened supplies, driving prices higher even as other key holiday foods show mixed trends.
Highly Pathogenic Avian Flu (HPAI) cases are rising. In the last week, seven commercial turkey, duck, and egg layer flocks were culled across five Midwest states and California.
While there has been an increase in outbreaks of Highly Pathogenic Avian Influenza (HPAI) this migration season, the CDC says the public health risk is low.
